Cite
MLA Citation
Thomas A. Miller et al.. “P3‐055: SYSTEMS BIOLOGY PLATFORM TO ENABLE NEUROINFLAMMATORY TARGET ID, VALIDATION, AND PATIENT SELECTION FOR DISEASE‐MODIFYING ALZHEIMER'S DISEASE THERAPEUTICS.” Alzheimer's & dementia, vol. 15, n.d., p. P947. http://access.bl.uk/ark:/81055/vdc_100103413779.0x000010